Viru-pos

Package Leaflet: Information for the Patient

Viru-POS, 30 mg/g, Eye Ointment

Aciclovir

Read the package leaflet carefully before using the medicine, as it contains important information for the patient.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Table of Contents of the Leaflet

• 1. What is Viru-POS and what is it used for
• 2. Important information before using Viru-POS
• 3. How to use Viru-POS
• 4. Possible side effects
• 5. How to store Viru-POS
• 6. Contents of the pack and other information

1. What is Viru-POS and what is it used for

Viru-POS eye ointment prevents the multiplication of certain viruses.
The indication for use is keratitis caused by the herpes simplex virus.

2. Important information before using Viru-POS

When not to use Viru-POS

Warnings and precautions

Before starting treatment with Viru-POS, discuss it with your doctor or pharmacist.
Wearing contact lenses during treatment of viral corneal infections with Viru-POS is contraindicated.
To ensure optimal treatment with Viru-POS, treatment should be started as soon as possible.
During treatment, you should visit your doctor 2-3 times a week for a check-up.
Immediately after applying the ointment, a transient, mild stinging sensation may occur.
Edition 07/2024

• 1.3.1 SPC, labelling and package leaflet

Viru-POS and other medicines

Tell your doctor or pharmacist about all medicines you are taking, or have recently taken, and any medicines you plan to take.
No interactions with other medicines are known.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before using this medicine.
Your doctor will only consider prescribing aciclovir if the expected benefits to the mother outweigh the potential risks to the fetus or baby.

Driving and using machines

Due to its consistency, the ointment temporarily impairs vision, which should be taken into account when driving, operating machinery, or using hazardous tools.

3. How to use Viru-POS

This medicine should always be used as directed by your doctor. If you are unsure, ask your doctor or pharmacist.
If you are using other eye drops or ointments, wait 15 minutes between each medicine and always apply the eye ointment last.
The recommended dose is a 1 cm long strip of ointment from the tube, which should be applied 5 times a day to the lower conjunctival sac (the pocket formed by pulling down the lower eyelid) every 4 hours, with a break at night. Treatment should continue for at least 3 days after the lesions have healed.
When applying the ointment, do not touch the eye, face, or any other surface with the tip of the tube.
Tilt your head back slightly and pull down the lower eyelid, placing the correct amount of ointment in the lower conjunctival sac. Then, close your eyelid slowly. After use, close the tube tightly.
If you feel that the effect of Viru-POS is too strong or too weak, consult your doctor.

Using more Viru-POS than recommended

If you use more of this medicine than recommended, contact your doctor or pharmacist immediately.

Missing a dose of Viru-POS

Do not take a double dose to make up for a missed dose.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Edition 07/2024

• 1.3.1 SPC, labelling and package leaflet

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been observed:
Very common (more than 1 in 10 patients): punctate superficial keratitis, which usually does not require premature discontinuation of treatment and heals without noticeable harmful effects.
Common (more than 1 in 100, but less than 1 in 10 patients): conjunctivitis and mild, transient burning sensation occurring immediately after application of the ointment.
Rare (more than 1 in 10,000, but less than 1 in 1,000 patients): blepharitis has occurred.
Very rare (less than 1 in 10,000 patients): immediate hypersensitivity reactions with angioedema (Quincke's edema, pale swelling, mainly of the face), urticaria may occur.
If severe allergic reactions (swelling of the hands, feet, ankles, face, lips, tongue, throat, difficulty swallowing or breathing, rash, urticaria) occur, discontinue use of the medicine and contact your doctor or the Emergency Department of the nearest hospital immediately.
If treatment needs to be discontinued due to side effects, inform your doctor, who will prescribe another medicine.

Reporting side effects

If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
PL-02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Viru-POS

Keep the medicine out of sight and reach of children.
Edition 07/2024

• 1.3.1 SPC, labelling and package leaflet

Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Do not store above 25°C.
Shelf-life after first opening of the tube: 1 month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What Viru-POS contains

The active substance is 30 mg of aciclovir.
The other ingredient is white petrolatum.

What Viru-POS looks like and contents of the pack

Viru-POS is a white-grey ointment in an aluminum tube with a screw cap.
The tube contains 4.5 g of ointment.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

URSAPHARM Poland Sp. z o.o., ul. Wybrzeże Gdyńskie 27, 01-531 Warsaw, Poland
Phone: 22 732 07 90
Fax: 22 732 07 99
e-mail: info@ursapharm.pl

Manufacturer:

URSAPHARM Arzneimittel GmbH, Industriestraße, 66129 Saarbrücken, Germany

Date of last revision of the leaflet:

Edition 07/2024